The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-(benzo[d][1,3]dioxol-5-yl)-N-(4-methoxybenzyl)pyrimidin-4-amine ID: ALA2392390
PubChem CID: 44820589
Max Phase: Preclinical
Molecular Formula: C19H17N3O3
Molecular Weight: 335.36
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: COc1ccc(CNc2ccnc(-c3ccc4c(c3)OCO4)n2)cc1
Standard InChI: InChI=1S/C19H17N3O3/c1-23-15-5-2-13(3-6-15)11-21-18-8-9-20-19(22-18)14-4-7-16-17(10-14)25-12-24-16/h2-10H,11-12H2,1H3,(H,20,21,22)
Standard InChI Key: VRHLLEYTPDHVSE-UHFFFAOYSA-N
Molfile:
RDKit 2D
25 28 0 0 0 0 0 0 0 0999 V2000
0.8158 -2.8973 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.8146 -3.7168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5227 -4.1258 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.5209 -2.4884 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3110 -1.6715 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-1.3099 -2.4910 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6064 -2.9000 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
0.1109 -2.4906 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
0.1081 -1.6679 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-0.6046 -1.2626 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-0.6105 -0.4454 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
-1.3130 -0.0390 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0263 -0.4497 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7244 -0.0423 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4299 -0.4524 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-3.4319 -1.2704 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.7178 -1.6767 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-2.0176 -1.2644 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
-4.1375 -1.6821 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
-4.1328 -2.4993 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2254 -2.8928 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.2343 -3.7168 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0208 -3.9631 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
3.4980 -3.2911 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.0064 -2.6297 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 22 2 0
21 4 2 0
4 1 1 0
5 6 2 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
10 11 1 0
8 1 1 0
11 12 1 0
12 13 1 0
13 14 2 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 13 1 0
16 19 1 0
19 20 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 21 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 335.36Molecular Weight (Monoisotopic): 335.1270AlogP: 3.49#Rotatable Bonds: 5Polar Surface Area: 65.50Molecular Species: NEUTRALHBA: 6HBD: 1#RO5 Violations: ┄HBA (Lipinski): 6HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 5.56CX LogP: 3.80CX LogD: 3.79Aromatic Rings: 3Heavy Atoms: 25QED Weighted: 0.77Np Likeness Score: -1.01
References 1. Coombs TC, Tanega C, Shen M, Wang JL, Auld DS, Gerritz SW, Schoenen FJ, Thomas CJ, Aubé J.. (2013) Small-molecule pyrimidine inhibitors of the cdc2-like (Clk) and dual specificity tyrosine phosphorylation-regulated (Dyrk) kinases: development of chemical probe ML315., 23 (12): [PMID:23642479 ] [10.1016/j.bmcl.2013.02.096 ]